Adaltis receives favourable report for diagnostic test for HIV

03-Aug-2006

Adaltis Inc. announced that a product evaluation report published by the Microbiological diagnostics Assessment Service, has ranked Adaltis' fourth generation test for HIV screening - the Detect-HIV(TM) (v.4) - as the second most sensitive microplate product among the diagnostic kits tested by the Service.

Detect-HIV(TM) (v.4) is an ultra-sensitive EIA test offering a sensitivity of 100% and a specificity of greater than 99.8%, for detection of all HIV antibodies types and subtypes tested and for the detection of antigen p24 to HIV-1. The report will expand new market opportunities for Detect-HIV(TM) (v.4) internationally.

Other news from the department research and development

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper